Do you offer OEM services?

Yes, OEM service is available for this product.

What payment terms do you accept?

We accept LC, T/T, D/P, PayPal, Western Union, and small-amount payments.

How is the quality of finished products inspected?

We perform 100% inspection including visual and function checks.

Lyi Alkaline Bacteriostasis Wash Cleaning Solution Ailex As450 Cleaner Reagent Biochemical Analyzer Wash Buffer

Name: Lyi Alkaline Bacteriostasis Wash Cleaning Solution Ailex As450 Cleaner Reagent Biochemical Analyzer Wash Buffer
Brand: Zhejiang Xinke Medical Technology Co., Ltd.
SKU: 2160835185

Zhejiang, ChinaZhejiang Xinke Medical Technology Co., Ltd.

US$1.00

1 Piece

Sample price:US$1.00/piece.Request sample

Product profile

Customization

Available

Type

IVD Reagent

Product

Mindray

Model NO.

JXK-164

Certificate

CE, MSDS, ISO13485

Transport Package

Carton

Specification

500ML

Trademark

xinke

Origin

China

HS Code

3822190090

Production Capacity

500000/Ctns

Key features

Wide Compatibility: Suitable for LYI Series and Mindray Series biochemical analyzers.

Comprehensive Certifications: Holds CE, ISO 9001, ISO 13485, and FSC certificates.

Flexible Customization: Offers flexible customization options for products.

OEM Service Available: Provides OEM services for major brands like Mindray.

Fast Lead Time: Peak and off-peak season lead time within 15 workdays.

Strict Quality Control: 100% inspection including visual and function checks.

Established Manufacturer: Manufacturer founded in 2004 with 20 years of export experience.

Low MOQ: Minimum Order Quantity starts from 1 piece.

Company profile

Importers and ExportersYears of Export Experience

Zhejiang Xinke Medical Technology Co., Ltd.

Zhejiang, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: OEM Service Available CertifiedCustomization Options: Flexible customization CertifiedExport Year: 20 Years CertifiedNearest Port: Ningbo PortAverage Response Time: ≤2.87h

AI-Powered supplier vetting

SummaryThe supplier operates in the clinical in vitro diagnostic reagent field and reports ten years of ISO9001 and ISO13485 quality-system certification. It offers flexible customization, has OEM experience with well-known brands, possesses self-managed import/export rights, and has exported for 20 years, with exports representing 51%–70% of total sales. Quality inspection procedures are documented and consistently followed, while stated lead times are within 15 working days in both peak and off-season. However, the supplier reports no inventory, overseas warehouse, overseas showroom, overseas agents or branches, offline trade-show participation, ODM service, SDK, recent new-product development, ERP, OA, CRM, SAP, or broader digitalization initiatives. Financial information is inconsistent or insufficiently interpretable in the provided records, so financial credibility cannot be determined.

Supplier typeThe supplier identifies itself as a company in the clinical in vitro diagnostic reagent field and has self-managed import/export rights with 20 years of export experience. This supports classification as an export-capable manufacturer or supplier in the medical in vitro diagnostics sector.

CertificationsThe company states that it has maintained ISO9001 and ISO13485 quality-system certifications for ten years. These explicitly documented certifications support a positive assessment of its quality-system credentials.

R&D capabilityThe supplier reports no new products in the past year, no ODM service, no available SDK, and no current enterprise digitalization or technical-transformation plan. These explicit limitations indicate weak demonstrated innovation capability.

Customization capabilityThe supplier explicitly provides flexible customization through both its R&D and design-service capabilities. This directly supports a positive assessment of customization capability, although ODM service is not offered.

Client casesThe supplier states that it provides OEM services for well-known brands, which is evidence of relevant customer experience. No specific brand names, project details, or verifiable case descriptions are provided, so the evidence is positive but limited.